BREAKING
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 8 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 8 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 8 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 9 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 9 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 9 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 9 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 9 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 10 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 10 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 8 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 8 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 8 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 9 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 9 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 9 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 9 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 9 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 10 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 10 hours ago
ADVERTISEMENT
Market News

AMETEK (AME) reports higher revenue and adjusted earnings for Q4 2025

AMETEK, Inc. (NYSE: AME), a leading provider of electronic instruments and electromechanical devices, reported an increase in sales and adjusted earnings for the fourth quarter of fiscal 2025.

February 3, 2026 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

AMETEK, Inc. (NYSE: AME), a leading provider of electronic instruments and electromechanical devices, reported an increase in sales and adjusted earnings for the fourth quarter of fiscal 2025.

AMETEK, Inc. (NYSE: AME), a leading provider of electronic instruments and electromechanical devices, reported an increase in sales and adjusted earnings for the fourth quarter of fiscal 2025.

  • Fourth-quarter sales were a record $2.0 billion, a 13% increase from the same period of 2024
  • Earnings, on a per-share basis, increased to $1.73 in Q4 from $1.67 in the year-ago quarter
  • Net income increased to $398.6 million from $387.3 million in the year-ago period
  • Adjusted earnings rose 7% year-over-year to a record $2.01 per share in the December quarter
  • Adjusted operating income was $523.0 million in Q4, up 12% versus last year’s fourth quarter
  • Operating cash flow was a record $584.3 million, and free cash flow came in at $527.3 million in Q4
  • For the first quarter of 2026, management expects overall sales to be up approximately 10%
  • Q1 adjusted earnings are anticipated to be in the range of $1.85 to $1.90 per share, up 6-9%
  • For fiscal 2026, the company expects overall sales to be up mid to high single digits compared to 2025.
  • Full-year adjusted earnings per share are expected to be in the range of $7.87 to $8.07, up 6% to 9%
ADVERTISEMENT